"Side effects of Vero cell vaccination against Covid-19 among medical students of Nepalgunj Medical College"-A Post Vaccination survey
K.C., R.; Malla, S.; Shrestha, M.; Siddiqui, S.; Pandey, A. J.; KC, N.; Adhikari, S.; KC, R.
Show abstract
Background and aimsSevere Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) is a highly transmissible virus causing Coronavirus disease (COVID-19). Its symptoms include fever, dry cough, and shortness of breath. Vaccine plays a significant role in controlling infectious disease and lesser health resources are used, and there is increased allocation of those resources for disease management. Vero Cell is an inactivated vaccine against COVID-19 manufactured by Sinopharm Company of China and recommended for people above 18 years by the World Health Organization. It is administered in two doses of 0.5 ml, 14-28 days apart. The goal of our study was to determine post-vaccination side effects of both the first(1st) and the second(2nd) dose among participants of Nepalgunj Medical College Teaching Hospital (NGMCTH), Kohalpur, Banke, Nepal. MethodsA prospective cross-sectional study was conducted among undergraduate medical students and intern doctors of Nepalgunj Medical College. A comprehensive structured questionnaire was designed and distributed following each dose of vaccination. Data were collected from 6th January 2022 to 6th April 2022 and entered in Microsoft Excel and analyzed using the statistical package for social sciences (SPSS) version 22. Analyzed data were presented using simple descriptive statistics with appropriate tables. ResultsOut of 156 participants, the majority were males (66.7%), within the age group of 21-24. The most frequently encountered symptom was pain at the injection site, predominantly seen in males. Among all the tested variables, the second dose of vaccination showed a significant association with sex. All the predominant symptoms exhibited a significant association following vaccination, except for pain at the injection site (p-value <0.05). ConclusionsVaccine has proven to be a lifesaving breakthrough during the peak of the COVID-19 outbreak and has been precisely efficacious in a developing country like Nepal.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of Confidence, Convenience, and Complacency; A Cross-sectional study 98%
- Acceptance of COVID-19 Vaccine in Pakistan Among Health Care Workers 97%
- Acceptance and Attitudes Toward COVID-19 Vaccines: A Cross-Sectional Study from Jordan 97%
Similar papers in this journal
Similar papers in this journal
- Breakthrough infection with SARS-CoV-2 and its predictors among healthcare workers in a medical college and hospital complex in Delhi, India 95%
- Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variant 95%
- Comparative study between first and second wave of COVID-19 deaths in India - a single center study 94%
Similar papers in this journal
- The burden of vaccine hesitancy for routine immunization in Yaounde-Cameroon: restrictive sampling technique 95%
- Health care workers’ self-perceived infection risk and COVID-19 vaccine uptake: a mixed methods study 95%
- Improving the last mile delivery of vaccines through an informed push model: experiences, opportunities and costs based on an implementation study in a rural district in Uganda 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.